NCT05681026 Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
| NCT ID | NCT05681026 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Hematopoietic Stem Cell Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-08-28 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-08-28 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To develop and measure the effects of a culturally sensitive yoga program for inpatients
Eligibility Criteria
Inclusion Criteria: 1. Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH; 2. Age 18 or older; 3. English, Hindi, or Swahili speaking; 4. Able to sign a written informed consent and be willing to follow protocol requirements. Exclusion Criteria: * Extreme mobility issues that preclude participating in the YT; * Major thought disorders such as schizophrenia or uncontrolled bipolar disorder; * HCT comorbidity score of 3 or higher, excluding cancer diagnoses
Contact & Investigator
Lorenzo Cohen, PHD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05681026 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic Stem Cell Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05681026 currently recruiting?
Yes, NCT05681026 is actively recruiting participants. Contact the research team at lcohen@mdanderson.org for enrollment information.
Where is the NCT05681026 trial being conducted?
This trial is being conducted at Houston, United States, Giddenahalli, India, Dar es Salaam, Tanzania.
Who is sponsoring the NCT05681026 clinical trial?
NCT05681026 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Lorenzo Cohen, PHD at M.D. Anderson Cancer Center. The trial plans to enroll 60 participants.